Literature DB >> 19683432

What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment.

L van Dam1, L Hol, E W de Bekker-Grob, E W Steyerberg, E J Kuipers, J D F Habbema, M L Essink-Bot, M E van Leerdam.   

Abstract

INTRODUCTION: In many countries uptake of colorectal cancer (CRC) screening remains low. AIM: To assess how procedural characteristics of CRC screening programmes determine preferences for participation and how individuals weigh these against the perceived benefits from participation in CRC screening.
METHODS: A discrete choice experiment was conducted among subjects in the age group of 50-75 years, including both screening-naïve subjects and participants of a CRC screening programme. Subjects were asked on their preferences for aspects of CRC screening programmes using scenarios based on pain, risk of complications, screening location, preparation, duration of procedure, screening interval and risk reduction of CRC-related death.
RESULTS: The response was 31% (156/500) for screening-naïve and 57% (124/210) for CRC screening participants. All aspects proved to significantly influence the respondents' preferences. For both groups combined, respondents required an additional relative risk reduction of CRC-related death by a screening programme of 1% for every additional 10 min of duration, 5% in order to expose themselves to a small risk of complications, 10% to accept mild pain, 10% to undergo preparation with an enema, 12% to use 0.75l of oral preparation combined with 12h fasting and 32% to use an extensive bowel preparation. Screening intervals shorter than 10 years were significantly preferred to a 10-year screening interval.
CONCLUSION: This study shows that especially type of bowel preparation, risk reduction of CRC related death and length of screening interval influence CRC screening preferences. Furthermore, improving awareness on CRC mortality reduction by CRC screening may increase uptake.

Entities:  

Mesh:

Year:  2010        PMID: 19683432     DOI: 10.1016/j.ejca.2009.07.014

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  33 in total

Review 1.  Risk as an attribute in discrete choice experiments: a systematic review of the literature.

Authors:  Mark Harrison; Dan Rigby; Caroline Vass; Terry Flynn; Jordan Louviere; Katherine Payne
Journal:  Patient       Date:  2014       Impact factor: 3.883

2.  Preferences for genetic testing for colorectal cancer within a population-based screening program: a discrete choice experiment.

Authors:  Jorien Veldwijk; Mattijs S Lambooij; Frank G J Kallenberg; Henk J van Kranen; Annelien L Bredenoord; Evelien Dekker; Henriëtte A Smit; G Ardine de Wit
Journal:  Eur J Hum Genet       Date:  2015-06-03       Impact factor: 4.246

Review 3.  Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments.

Authors:  S Wortley; G Wong; A Kieu; K Howard
Journal:  Patient       Date:  2014       Impact factor: 3.883

4.  What is most important to patients when deciding about colorectal screening?

Authors:  Avlin Imaeda; Danielle Bender; Liana Fraenkel
Journal:  J Gen Intern Med       Date:  2010-03-23       Impact factor: 5.128

5.  Attributes Used for Cancer Screening Discrete Choice Experiments: A Systematic Review.

Authors:  Rebekah Hall; Antonieta Medina-Lara; Willie Hamilton; Anne E Spencer
Journal:  Patient       Date:  2021-10-21       Impact factor: 3.883

6.  Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial.

Authors:  Thomas R de Wijkerslooth; Margriet C de Haan; Esther M Stoop; Marije Deutekom; Paul Fockens; Patrick M M Bossuyt; Maarten Thomeer; Marjolein van Ballegooijen; Marie-Louise Essink-Bot; Monique E van Leerdam; Ernst J Kuipers; Evelien Dekker; Jaap Stoker
Journal:  BMC Gastroenterol       Date:  2010-05-19       Impact factor: 3.067

Review 7.  Discrete choice experiments in health economics: a review of the literature.

Authors:  Michael D Clark; Domino Determann; Stavros Petrou; Domenico Moro; Esther W de Bekker-Grob
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

8.  Colorectal Cancer Screening: Preferences, Past Behavior, and Future Intentions.

Authors:  Carol Mansfield; Donatus U Ekwueme; Florence K L Tangka; Derek S Brown; Judith Lee Smith; Gery P Guy; Chunyu Li; Brett Hauber
Journal:  Patient       Date:  2018-12       Impact factor: 3.883

9.  Responses to procedural information about colorectal cancer screening using faecal occult blood testing: the role of consideration of future consequences.

Authors:  Christian von Wagner; Anna Good; Samuel G Smith; Jane Wardle
Journal:  Health Expect       Date:  2011-04-19       Impact factor: 3.377

10.  Artificial intelligence in breast cancer screening: primary care provider preferences.

Authors:  Nathaniel Hendrix; Brett Hauber; Christoph I Lee; Aasthaa Bansal; David L Veenstra
Journal:  J Am Med Inform Assoc       Date:  2021-06-12       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.